Particularly NBCn1 (SLC4A7) is upregulated in breast cancer cells by ErB2/HER2 oncogene and its elevated expression correlates with poor prognosis of patients with mammary tumors (Lauritzen et al., 2010; Boedtkjer et al., 2013). Here, SLC4A7 is linked to breast carcinoma.